We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




T Cell Training Enhances Immune System Diversity

By Biotechdaily staff writers
Posted on 19 Dec 2002
A recent study described the role of the major histocompatability complex (MHC) system in the training and activation of immune T cells. More...
The study was published in the November 29, 2002, issue of Science.

Investigators from the Oregon Health and Science University (Beaverton, USA) used mice infected with herpes simplex virus to evaluate the quality of the T cell response against the virus. They concentrated on molecules of the major histocompatability complex (MHC) system exposed on the surface of infected cells and alert T cells.

"The MHC molecules have two roles. First, they act like the traffic cops in the body. They look for invaders and, once they find them, they call in T cells to defeat a pathogen,” explained senior author Dr. Janko Nikolich-Zugich, a senior scientist at the Oregon Health and Science University Vaccine and Gene Therapy Institute. "But, just as importantly, they also ‘train' T cells when the pathogen is not around. They do this by selecting and expanding only those T cells that can be appropriately directed to find and destroy a pathogen when it attacks.”

By providing ‘training' to a wide, diverse set of T cells, some MHC molecules can ensure that the pathogen will be met by the very best T cells, able to kill the pathogen promptly at the beginning of infection. The more diverse set of T cells an animal has, the better chance the cells have of detecting a pathogen early and successfully fighting it off. The fact that as people age their T cell diversity drops helps explain why seniors are more susceptible to the flu and other diseases than the rest of the population

"This research is of particular interest to populations that are highly vulnerable to disease, such as the aging population,” said Dr. Nikolich-Zugich. "We hope that years down the road, this research finding will help us boost the immune systems of the elderly.”



Related Links:
Oregon Health and Science University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.